Gritstone bio to Participate in 43rd Annual Cowen Healthcare Conference

Rhea-AI Summary

Gritstone bio, a clinical-stage biotechnology firm, announced that its Co-founder and CEO, Andrew Allen, will participate in the "Novel Immuno-Oncology" panel at the Cowen 43rd Annual Healthcare Conference. The event is scheduled for March 6, 2023, from 9:10 to 10:10am ET, at the Boston Marriott Copley Place. A live webcast of the panel will be accessible, with an archived replay available for 30 days.

Gritstone is focused on developing potent vaccines targeting viral diseases and solid tumors, utilizing innovative vectors to enhance immune response. Investors and media inquiries can be directed to their respective contacts provided in the release.

EMERYVILLE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced that Andrew Allen, M.D., Ph.D., Gritstone’s Co-founder, President and Chief Executive Officer will participate in the “Novel Immuno-Oncology” panel at the Cowen 43^rd Annual Healthcare Conference on March 6, 2023.

Panel Details
Title: Novel I-O Corporate Panel
Date and Time: Monday, March 6, 2023 from 9:10 to 10:10am ET
Location: Boston Marriott Copley Place, 110 Huntington Ave, Boston, MA 02116

A live webcast of the panel will be available at https://ir.gritstonebio.com/investors/events. An archived replay will be accessible for 30 days following the event.

About Gritstone bio
Gritstone is working to create the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets and have programs in viral diseases and solid tumors. Independently and with our partners, we are advancing a portfolio of product candidates with the aim of improving patient outcomes and eliminating disease. www.gritstonebio.com

Gritstone Contacts
Investors:
George E. MacDougall
Director, Investor Relations & Corporate Communications
Gritstone bio, Inc.
ir@gritstone.com

Media:
Dan Budwick
1AB
(973) 271-6085
dan@1abmedia.com 

FAQ

When is Gritstone bio's participation in the Cowen 43rd Annual Healthcare Conference?

Gritstone bio will participate on March 6, 2023, from 9:10 to 10:10am ET.

Where will the Cowen 43rd Annual Healthcare Conference panel take place?

The panel will take place at the Boston Marriott Copley Place.

Who will represent Gritstone bio at the conference?

Andrew Allen, Co-founder and CEO, will represent Gritstone bio.

Will there be a live webcast for the Gritstone bio panel?

Yes, a live webcast will be available during the panel.

How long will the webcast replay be available after the event?

The archived replay will be accessible for 30 days following the event.

What is the focus of Gritstone bio's research?

Gritstone bio focuses on developing potent vaccines for viral diseases and solid tumors.